{{'Search' | translate}}
 

AccuGel 19:1 (40%)

AccuGel 19:1(40%)

Company: National Diagnostics
Catalog#: EC-850
Bio-protocol()
Company-protocol()
Other protocol()

In vitro Assay to Measure DNA Polymerase β Nucleotide Insertion Coupled with the DNA Ligation Reaction during Base Excision Repair
Author:
Date:
2017-06-20
[Abstract]  We previously reported that oxidized nucleotide insertion by DNA polymerase β (pol β) can confound the DNA ligation step during base excision repair (BER) (Çağlayan et al., 2017). Here, we describe a method to investigate pol β nucleotide insertion coupled with DNA ligation, in the same reaction mixture including dGTP or 8-oxo-dGTP, pol β and DNA ligase I. This in vitro assay enables us to measure the products for correct vs. oxidized nucleotide insertion, DNA ligation, and ligation failure, i.e., abortive ligation products, as a function of reaction time. This protocol complements our previous publication and describes an efficient way to analyze activities of BER enzymes and the functional interaction between pol β and DNA ligase I in vitro. [摘要]  我们以前报告说,通过DNA聚合酶β(polβ)的氧化的核苷酸插入可能会在碱基切除修复(BER)(Çağlayan等,2017)期间混淆DNA连接步骤。 在这里,我们描述了在与dGTP或8-氧代-dGTP,polβ和DNA连接酶I相同的反应混合物中研究与DNA连接相结合的polβ核苷酸插入的方法。该体外测定使得我们能够测量产物的正确性 与氧化核苷酸插入,DNA连接和连接失败,即流产结扎产物,作为反应时间的函数。 该协议补充了我们以前的出版物,并描述了一种有效的方法来分析BER酶的活性和polβ和DNA连接酶I在体外的功能相互作用。
【背景】该方案是观察BER路径的最后两个步骤:通过连接酶I通过polβ进行核苷酸插入和DNA连接。使用该方案,在体外在同一反应混合物中测量两种反应作为时间的函数。原始实体是在模拟BER中间体的单核苷酸缺口DNA底物上分析BER酶polβ和DNA连接酶I。这些BER酶与此BER中间体结合并起作用。该方案中使用的DNA底物包括在5'和3'端的荧光标记,使我们能够观察DNA底物的单核苷酸插入和DNA连接。与DNA连接偶联的polβ核苷酸插入模拟了切口DNA中间体从核苷酸插入步骤切换或引导到BER途径期间的连接步骤。使用该方案,也可以在polβ氧化的核苷酸(8-氧代-dGTP)插入后测量连接失败或者终止连接。这通过在BER中间体的5'-末端添加腺苷酸(AMP)基团进行定量来实现。该方案也可用于测量与其他DNA聚合酶和DNA连接酶连接的核苷酸插入。 ...

Enzymatic Activity Assays for Base Excision Repair Enzymes in Cell Extracts from Vertebrate Cells
Author:
Date:
2015-06-05
[Abstract]  We previously reported enzymatic activity assays for the base excision repair (BER) enzymes DNA polymerase β (pol β), aprataxin (APTX), and flap endonuclease 1 (FEN1) in cell extracts from Saccharomyces cerevisiae (Çağlayan and Wilson, 2014). Here, we describe a method to prepare cell extracts from vertebrate cells to investigate these enzymatic activities for the processing of the 5´-adenylated-sugar phosphate-containing BER intermediate. This new protocol complements our previous publication. The cell lines used are wild-type and APTX-deficient human lymphoblast cells from an Ataxia with Oculomotor Apraxia Type 1 (AOA1) disease patient, wild-type and APTX-null DT40 chicken B cells, and mouse embryonic fibroblast (MEF) cells. This protocol is a quick and efficient way to make ... [摘要]  我们先前报道了来自酿酒酵母(Saccharomyces cerevisiae)的细胞提取物中的碱基切除修复(BER)酶DNA聚合酶β(polβ),aprataxin(APTX)和瓣膜内切核酸酶1(FEN1)的酶活性测定 和Wilson,2014)。 在这里,我们描述了一种从脊椎动物细胞中制备细胞提取物以研究这些酶活性用于加工含5'-腺苷酸化糖 - 磷酸酯的BER中间体的方法。 这个新协议补充了我们以前的出版物。 所使用的细胞系是来自具有Oclomotor Apraxia 1型(AOA1)疾病患者,野生型和APTX无效DT40鸡B细胞和小鼠胚胎成纤维细胞(MEF)细胞的共济失调的野生型和APTX缺陷型人淋巴母细胞。 这个协议是一个快速和有效的方式来制作脊椎动物细胞提取没有使用商业套件。

Comments